News

Find News

Filter articles

Showing 41 to 50 of 3607 results

COVID-19 IP waiver faces uncertain future

US31-03-2022Muireann Bolger

The future of the IP waiver related to the COVID-19 vaccine looks uncertain after the US Trade Representative confirmed no agreements had yet been reached between US, the EU, India and South Africa.

Gilead loses bid to quash parallel antitrust HIV lawsuit

US31-03-2022Muireann Bolger

Gilead Sciences has failed to prevent insurer Aetna from pursuing its lawsuit in a US state court, as it faces a spate of antitrust complaints alleging that it used pay-for-delay deals to maintain the high costs of HIV drugs.

Medtech groups say ‘unlawful’ DMCA exemption should be waived

US31-03-2022Alex Baldwin

Medical device companies have asked a US federal judge to eliminate an exemption that allows the bypassing of technological protections for copyrighted software if it is in service of using or repairing medical devices.

Illumina gets $8m plus injunction from DNA sequencing suit

China, US29-03-2022Alex Baldwin

DNA-sequencing company Illumina has convinced a California court to bar Chinese pharma firm BGI Genomics from selling technology that infringes its genome-sequencing patents.

ImmunoGen cancer treatment application gets another chance

US29-03-2022Alex Baldwin

ImmunoGen has been given the go-ahead to revive its patent application for a cancer treatment dosage following a Federal Circuit ruling on Friday.

MSD, Pfizer try to stop three Steglatro generics

US29-03-2022Alex Baldwin

Merck Sharp & Dohme and Pfizer have filed three complaints with the Delaware district court to attempt to shut down proposed generics of Steglatro—a diabetes treatment that Pfizer licences to MSD.

Campaigners ask US govt to force down prices for common drugs

US24-03-2022Alex Baldwin

Entities backing the Make Meds Affordable campaign have asked US health authorities President Biden to end “patent monopolies” on six common medicines to bring down prices.

Sun unit resolves antitrust lawsuit for $485m

US24-03-2022Muireann Bolger

Sun Pharmaceuticals has agreed to pay $485 million to settle an antitrust lawsuit relating to a generic drug application filed by its subsidiary, Ranbaxy, ending years of litigation.

Novo Nordisk and Sandoz settle Victoza patent suit

US24-03-2022Alex Baldwin

Novo Nordisk and Sandoz have settled an ongoing patent dispute over the blockbuster diabetes treatment Victoza before the companies were meant to face trial in April.

Takeda, Arbor aim to stop Turkish copies of high blood pressure drug

Turkey, US22-03-2022Muireann Bolger

Takeda Pharmaceutical and Arbor Pharmaceuticals are seeking to block Turkey-based EastPharma from releasing a generic version of the blockbuster high blood pressure medication, Edarbi.

Showing 41 to 50 of 3607 results

LSIPR